Cancer diagnostic AI · Medical imaging analytics · Response biomarkers

Lunit

A medical-AI company developing imaging-analysis tools for cancer diagnosis and biomarkers predicting response to cancer therapies. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

Business categories Enterprise & Industry AI Applications · Cloud & Enterprise Software · primary AI Drug Discovery & Precision Medicine · Biopharma & Life Sciences

Other companies in the same category

328130.KQ Updated Jul 11, 2026 5 AI consumers· 2 recurring

Annual return · 2026-10-08'23+230.7%'24+11.4%'25-41.1%YTD-39.5%
Money in ▸·
Lunit
▸ Money out·

Financials & Segments

  • Segments · Cancer-diagnosis AI (Insight) · Treatment-response prediction (Scope)

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com